Skip to main content
Top
Published in: Pediatric Cardiology 3/2005

01-06-2005

Percutaneous Closure of Perimembranous Ventricular Septal Defects with the Eccentric Amplatzer Device: Multicenter Follow-up Study

Authors: J. Masura, W. Gao, P. Gavora, K. Sun, A.Q. Zhou, S. Jiang, L. Ting-liang, Y. Wang

Published in: Pediatric Cardiology | Issue 3/2005

Login to get access

Abstract

Using an Amplatzer membranous eccentric occluder, 186 patients with an average weight of 43.5 kg (range 12.5–77) underwent attempted catheter closure of a perimembranous venricular septal defect (PMVSD). Their age ranged from 3 to 51 years, with the an average age being 15.9 years. The patients were divided into three groups according to morphology of PMVSD: 106 patients with single PMVSD, 63 patients with single PMVSD with aneurysmatic formation, and 17 patients with multiple VSD with aneurysmatic formation. Using angiography, PMVSDs were measured to be between 2.5 and 12 mm, with an average of 5.1 mm. In the third group of patients, we did not measure the size of PMVSD and a device was selected according to the size of entry to the aneurysm. The device was successfully implanted in all patients. The immediate closure rate was 90% in the first group, increasing to 100% at 1 month and remained at that level during follow-up. The immediate closure rate in the second group was 98% and remained the same during follow-up. The immediate closure rate in the third group was 89% and during 1 year of follow-up remained the same. There was no clinical evidence of hemolysis and no incidence of device embolization or bacterial endocarditis after implantation.
Before the procedure, all patients showed normal electrocardiogram (ECG) or left ventricle enlargement. After the procedure (at least 3 months later) ECG showed left anterior hemiblock (LAH) in nine patients, complete right bundle branch block in eight patients, and incomplete right bundle branch block in seven patients. A complete heart block (CHB) developed in 2 patients after the procedure (1.07%). The first patient developed LAH immediately after closure and CHB within 24 hours, The heart rate was 28 beats per minute. After treatment with steroids and atropine, CHB changed to sinus rhythm with LAH within 2 months. One year later, the ECG revealed the same findings. The second patient developed CHB immediately after the procedure and was on temporary pacing for 1 week. After 1 month, the patient recovered to sinus rhythm and ECG showed LAH.
Literature
1.
go back to reference Arora, R, Trehan, V, Kumar, A, et al. 2003Trancatheter closure of congenital ventricular septal defects experience with various devicesJ Cardiol168391CrossRef Arora, R, Trehan, V, Kumar, A,  et al. 2003Trancatheter closure of congenital ventricular septal defects experience with various devicesJ Cardiol168391CrossRef
2.
go back to reference Backer, CL, Winters, RC, Zales, VR, et al. 1993Restrictive ventricular septal defect: how small is too small to close?Ann Thorac Surg5610141018CrossRefPubMed Backer, CL, Winters, RC, Zales, VR,  et al. 1993Restrictive ventricular septal defect: how small is too small to close?Ann Thorac Surg5610141018CrossRefPubMed
3.
go back to reference Bass, JL, Karla, GS, Arora, R 2003Initial human experience with the Amplatzer perimembranous ventricular septal occluder deviceCathet Cardiovasc Interv58238245CrossRef Bass, JL, Karla, GS, Arora, R 2003Initial human experience with the Amplatzer perimembranous ventricular septal occluder deviceCathet Cardiovasc Interv58238245CrossRef
4.
go back to reference Gu, X, Han, YM, Titus, JL, et al. 2000Transcatheter closure of membranous ventricular septal defects with a new Nitinol prosthesis in a natural swine modelCathet Cardiovasc Interv50502509CrossRef Gu, X, Han, YM, Titus, JL,  et al. 2000Transcatheter closure of membranous ventricular septal defects with a new Nitinol prosthesis in a natural swine modelCathet Cardiovasc Interv50502509CrossRef
5.
go back to reference Hijazy, ZM 2003Catheter closure of atrial septal and ventricular septal defects using the Amplatzer devicesHeart Lung Circ12S63S72CrossRef Hijazy, ZM 2003Catheter closure of atrial septal and ventricular septal defects using the Amplatzer devicesHeart Lung Circ12S63S72CrossRef
6.
go back to reference Hijazi, ZM, Hakim, F, Haweleh, AA, et al. 2002Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experienceCathet Cardiovasc Interv56508515CrossRef Hijazi, ZM, Hakim, F, Haweleh, AA,  et al. 2002Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experienceCathet Cardiovasc Interv56508515CrossRef
7.
go back to reference Hill, SL, Berul, CI, Patel, HT, et al. 2000Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluderJ Interv Card Electrophysiol4469CrossRefPubMed Hill, SL, Berul, CI, Patel, HT,  et al. 2000Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluderJ Interv Card Electrophysiol4469CrossRefPubMed
8.
go back to reference Pedra, CA, Pedra, SR, Esteves, CA, et al. 2004Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerationsCathet Cardiovasc Interv61403410CrossRef Pedra, CA, Pedra, SR, Esteves, CA,  et al. 2004Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerationsCathet Cardiovasc Interv61403410CrossRef
9.
go back to reference Rigby, ML, Redington, AN 1994Primary transcatheter umbrella closure of perimembranous ventricular septal defectsBr Heart J72368371PubMed Rigby, ML, Redington, AN 1994Primary transcatheter umbrella closure of perimembranous ventricular septal defectsBr Heart J72368371PubMed
10.
go back to reference Rudolph, AM 2001Ventricular septal defectRudolph, AM eds. Congenital Diseases of the heart: Clinical–Physiological Considerations2FuturaArmonk, NY197244 Rudolph, AM 2001Ventricular septal defectRudolph, AM eds. Congenital Diseases of the heart: Clinical–Physiological Considerations2FuturaArmonk, NY197244
11.
go back to reference Sideris, EB, Walsh, KP, Haddad, JL, et al. 1997Occlusion of congenital ventricular septal defetcs by the buttoned deviceHeart77276279PubMed Sideris, EB, Walsh, KP, Haddad, JL,  et al. 1997Occlusion of congenital ventricular septal defetcs by the buttoned deviceHeart77276279PubMed
12.
go back to reference Thanopoulos, BD, Tsaousis, GS, Karanasios, E, Eleftherakis, NG, Papp, C 2003Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in childrenHeart89918922CrossRefPubMed Thanopoulos, BD, Tsaousis, GS, Karanasios, E, Eleftherakis, NG, Papp, C 2003Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in childrenHeart89918922CrossRefPubMed
13.
go back to reference Vogel, M, Rigby, ML, Shore, D 1996Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrellaPediatr Cardiol17416418CrossRefPubMed Vogel, M, Rigby, ML, Shore, D 1996Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrellaPediatr Cardiol17416418CrossRefPubMed
Metadata
Title
Percutaneous Closure of Perimembranous Ventricular Septal Defects with the Eccentric Amplatzer Device: Multicenter Follow-up Study
Authors
J. Masura
W. Gao
P. Gavora
K. Sun
A.Q. Zhou
S. Jiang
L. Ting-liang
Y. Wang
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 3/2005
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-005-1003-7

Other articles of this Issue 3/2005

Pediatric Cardiology 3/2005 Go to the issue

OriginalPaper

From Other Journals